Showing results (851-860 of 4,634) with videos related to

Sort By:
Pageof 464
Anti-Cancer Drugs|June 24, 2016
Investigation of cellular mechanisms involved in apoptosis induced by a synthetic naphthylchalcone in acute leukemia cell linesMariana Franzoni Maioral, Ana Carolina Rabello de Moraes, Karen Ristau Sgambatti, et al.
Anti-Cancer Drugs|July 21, 2017
A case of resistance to tyrosine kinase inhibitor therapy: small cell carcinoma transformation concomitant with plasma-genotyped T790M positivityYanjun Xu, Zhiyu Huang, Lei Gong, et al.
Anti-Cancer Drugs|May 11, 2016
Novel mechanisms involving chemically modified tetracycline 3 cytotoxicityLin Zhao, Jiaying Xu, Yang Jiao, et al.
Anti-Cancer Drugs|May 14, 2016
Eicosapentaenoic acid induced SKOV-3 cell apoptosis through ERK1/2-mTOR-NF-κB pathwaysLirong Han, Yuanyuan Zhang, Meng Meng, et al.
Anti-Cancer Drugs|May 18, 2016
In-vitro and in-vivo evaluation of the anticancer activity of diruthenium-2, a new trithiolato arene ruthenium complex [(η6-p-MeC6H4Pri)2Ru2(μ-S-p-C6H4OH)3]ClDarina Muthná, Pavel Tomšík, Radim Havelek, et al.
Anti-Cancer Drugs|June 3, 2016
Aprepitant, granisetron, and dexamethasone versus palonosetron and dexamethasone for prophylaxis of cisplatin-induced nausea and vomiting in patients with upper gastrointestinal cancer: a randomized crossover phase II trial (KDOG 1002)Kenji Ishido, Katsuhiko Higuchi, Mizutomo Azuma, et al.
Anti-Cancer Drugs|June 3, 2016
Cytosine arabinoside and daunorubicin induction therapy in a patient with acute myeloid leukemia on chronic hemodialysisEilon Krashin, Osnat J Dolberg, Ilana Hellmann, et al.
Anti-Cancer Drugs|June 9, 2016
Seven low-mass ions in pretreatment serum as potential predictive markers of the chemoradiotherapy response of rectal cancerKangsan Roh, Seung-Gu Yeo, Byong Chul Yoo, et al.
Anti-Cancer Drugs|June 9, 2016
Heterogeneous expression of A33 in colorectal cancer: possible explanation for A33 antibody treatment failureAntuani R Baptistella, Marcos Vinicios Salles Dias, Samuel Aguiar, et al.
Anti-Cancer Drugs|December 9, 2017
Influence of the alkylating function of aldo-Ifosfamide on the anti-tumor activityGeorg Voelcker
Pageof 464